These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 19965325)
21. The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Zhang Y; Zhang P; Mu Y; Gao M; Wang JR; Wang Y; Su LQ; Hou YL Clin Pharmacol Ther; 2010 Oct; 88(4):521-31. PubMed ID: 20811347 [TBL] [Abstract][Full Text] [Related]
22. [Role of ACE-inhibitors in preventing atrial fibrillation relapses in normotensive patients]. Belluzzi F; Sernesi L; Centola M; Perlini S Recenti Prog Med; 2009 Nov; 100(11):508-11. PubMed ID: 20066882 [TBL] [Abstract][Full Text] [Related]
23. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
24. [Upstream therapy of atrial fibrillation in patients with heart failure]. Alboni P; Gianfranchi L; Pacchioni F G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248 [TBL] [Abstract][Full Text] [Related]
25. [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker]. Goette A Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S103-7. PubMed ID: 16921445 [No Abstract] [Full Text] [Related]
26. The therapeutic role of RAS blockade in chronic heart failure. Werner CM; Böhm M Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420 [TBL] [Abstract][Full Text] [Related]
27. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation. Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308 [TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of angiotensin-converting enzyme inhibitors in the maintenance of sinus rythm after conversion of arterial fibrillation]. Grecu M; Olteanu RO; Olteanu SS; Georgescu CA Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):607-12. PubMed ID: 18293688 [TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis. Li TJ; Zang WD; Chen YL; Geng N; Ma SM; Li XD Int J Clin Pract; 2013 Jun; 67(6):536-43. PubMed ID: 23557493 [TBL] [Abstract][Full Text] [Related]
30. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. Casaclang-Verzosa G; Gersh BJ; Tsang TS J Am Coll Cardiol; 2008 Jan; 51(1):1-11. PubMed ID: 18174029 [TBL] [Abstract][Full Text] [Related]
31. Renin-angiotensin system inhibitors can suppress atrial fibrillation recurrence after encircling ipsilateral pulmonary vein isolation in patients with a non-dilated left atrium. Takigawa M; Yamada T; Yoshida Y; Ando M; Ishikawa K; Aoyama Y; Yamamoto T; Inoue N; Tatematsu Y; Nanasato M; Kato K; Tsuboi N; Hirayama H J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):487-95. PubMed ID: 22634400 [TBL] [Abstract][Full Text] [Related]
32. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088 [TBL] [Abstract][Full Text] [Related]
33. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation]. Disertori M; Zeni P; Quintarelli S; Bonmassari R G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320 [TBL] [Abstract][Full Text] [Related]
34. Renin-angiotensin system blockade is associated with the long-term protection against cardiac remodeling after cardioversion in hypertensive patients with atrial fibrillation. Egami Y; Nishino M; Taniike M; Makino N; Kato H; Shutta R; Yamaguchi H; Tanouchi J; Yamada Y Tohoku J Exp Med; 2010 Jul; 221(3):251-5. PubMed ID: 20595797 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation. Lip GY; Frison L; Grind M J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713 [TBL] [Abstract][Full Text] [Related]
36. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results. Durin O; Pedrinazzi C; Inama G J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747 [TBL] [Abstract][Full Text] [Related]
37. Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis. Jibrini MB; Molnar J; Arora RR Am J Ther; 2008; 15(1):36-43. PubMed ID: 18223352 [TBL] [Abstract][Full Text] [Related]
38. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation. Tsai CT; Lai LP; Hwang JJ; Chen WP; Chiang FT; Hsu KL; Tseng CD; Tseng YZ; Lin JL J Hypertens; 2008 Mar; 26(3):570-82. PubMed ID: 18300870 [TBL] [Abstract][Full Text] [Related]
39. Electrical cardioversion for AF-the state of the art. Gall NP; Murgatroyd FD Pacing Clin Electrophysiol; 2007 Apr; 30(4):554-67. PubMed ID: 17437583 [No Abstract] [Full Text] [Related]
40. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation. Baker WL; White CM Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]